Alaunos Therapeutics Reports Board and Officer Changes
Ticker: TCRT · Form: 8-K · Filed: Jul 22, 2025 · CIK: 1107421
| Field | Detail |
|---|---|
| Company | Alaunos Therapeutics, INC. (TCRT) |
| Form Type | 8-K |
| Filed Date | Jul 22, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, management-change, officer-appointment
TL;DR
Alaunos Therapeutics shakes up its board and exec team, filing 8-K on July 16, 2025.
AI Summary
Alaunos Therapeutics, Inc. announced on July 16, 2025, a change in its board of directors. Specifically, the company reported the departure of certain officers and the election of new directors, alongside updates to compensatory arrangements for its officers. The filing details these changes in corporate governance and executive compensation.
Why It Matters
Changes in a company's board and executive team can signal shifts in strategy, operational focus, or financial health, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can indicate underlying issues or strategic realignments that may affect the company's future prospects.
Key Numbers
- 001-33038 — SEC File Number (Identifies the company's filings with the SEC.)
- 84-1475642 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Alaunos Therapeutics, Inc. (company) — Registrant
- July 16, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Houston, TX (location) — Principal executive offices
FAQ
What specific roles were affected by the departure of certain officers?
The filing indicates changes in 'Departure of Directors or Certain Officers' and 'Appointment of Certain Officers' but does not specify the exact roles that departed or were appointed in this excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on July 16, 2025.
What is the principal executive office address for Alaunos Therapeutics, Inc.?
The principal executive office address is 2617 Bissonnet St Suite 233, Houston, TX 77005.
What is the SIC code for Alaunos Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Alaunos Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What other items are covered in this 8-K filing besides director and officer changes?
Besides director and officer changes, the filing also covers 'Election of Directors' and 'Compensatory Arrangements of Certain Officers'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 22, 2025 regarding Alaunos Therapeutics, Inc. (TCRT).